CellSourceCellSource Co.,Ltd.4880東証プライムサービス業FY ending Oct 2025, consolidated, J-GAAP
CellSource brought in ¥4.36B in revenue.
Out of every ¥100 of sales, about ¥3 is left as operating profit.
Revenue changed -3.4% from the prior year, operating profit -89.4%.
Revenue -3.4% · profit -89.4%, calculated from disclosed figures.
Operating leverage: 25.94× (profit growth ÷ revenue growth)
FY ending Oct 2023 → FY ending Oct 2024
FY ending Oct 2023 → FY ending Oct 2024
For every ¥100 CellSource sells, how much goes where, and how much is kept.
Aligned fiscal years compare the shares of revenue remaining as gross, core, and net profit. Missing years are left unconnected.
EDINET (FSA Japan)
有価証券報告書-第9期(2023/11/01-2024/10/31)
EDINET (FSA Japan)
有価証券報告書-第8期(2022/11/01-2023/10/31)
EDINET (FSA Japan)
有価証券報告書-第7期(2021/11/01-2022/10/31)
EDINET (FSA Japan)
有価証券報告書-第6期(令和2年11月1日-令和3年10月31日)
EDINET (FSA Japan)
有価証券報告書-第5期(令和1年11月1日-令和2年10月31日)
Extracted from XBRL: 47 / Derived from other figures: 1
Spotted an error? Report it (corrections keep the original record)
Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.